Supplementary Figure 4 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure 4: In vivo efficacy of TAC01-CLDN18.2 across different donors in the OE19 tumor model.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165052945